{
  "documentMetadata": {
    "title": "Toxic Shock Syndrome (TSS), Staphylococcal",
    "sourceFile": "Toxic Shock Syndrome (TSS), Staphylococcal.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Staphylococcal Toxic Shock Syndrome (TSS)"
    },
    {
      "type": "paragraph",
      "text": "Staphylococcal TSS is a toxin-mediated illness caused by Staphylococcus aureus. It is classically associated with tampon use in menstruating women, but it can also occur in other settings such as surgical wound infections."
    },
    {
      "type": "header",
      "level": 2,
      "text": "Clinical Criteria"
    },
    {
      "type": "list",
      "items": [
        "Fever >38.9°C (102°F)",
        "Hypotension",
        "Diffuse macular erythroderma",
        "Desquamation, particularly of the palms and soles, 1-2 weeks after onset of illness",
        "Involvement of three or more organ systems"
      ]
    },
    {
      "type": "header",
      "level": 2,
      "text": "Treatment"
    },
    {
      "type": "paragraph",
      "text": "Management includes aggressive fluid replacement, vasopressors, and removal of the source of infection (e.g., tampon removal, wound debridement)."
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "strengthOfRecommendation": "Recommended",
        "appliesTo": {
          "description": "Patients with staphylococcal TSS"
        },
        "components": [
          {
            "drug": "Clindamycin",
            "dose": "600-900 mg",
            "route": "IV",
            "frequency": "every 8 hours"
          },
          {
            "drug": "Vancomycin or Nafcillin/Oxacillin",
            "connector": "+"
          }
        ],
        "notes": "Clindamycin is used for its antitoxin effect. Vancomycin is used for MRSA coverage, while nafcillin or oxacillin is used for MSSA."
      }
    }
  ]
}